BIO-RAD LABORATORIES, INC. (BIO) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	8-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Net sales	2,922.5	2,545.6	2,311.7	2,289.4	2,160.2	2,068.2	2,019.4	2,175.0
Net sales growth	14.8%	10.1%	1.0%	6.0%	4.4%	2.4%	-7.2%	2.0%
Cost of goods sold		1,107.8	1,054.7	1,066.3	972.5
Gross profit	1,640.7	1,437.8	1,257.0	1,223.2	1,187.7	1,138.1	1,121.7	1,178.5
Gross margin	56.1%	56.5%	54.4%	53.4%	55.0%	55.0%	55.5%	54.2%
Selling, general and administrative expense	879.6	800.3	824.6	834.8	806.8	816.7	762.0	808.2
Research and Development Expense	271.7	226.6	202.7	199.2	250.2	205.9	193.0	220.3
Segment profit (loss)	489.4	411.0	229.7	-103.3	119.3	53.2	166.7	150.0
Operating margin	16.7%	16.1%	9.9%	-4.5%	5.5%	2.6%	8.3%	6.9%
Interest expense	-1.6	-21.9	-23.4	-24.0	-23.0	-21.9	-21.7	-22.1
Foreign exchange (gains) losses, net		1.8	2.2	2.9	9.1	4.5	10.2	9.3
Other Nonoperating Income (Expense)	26.8	24.5	26.1	36.6	10.7	14.9	11.1	13.0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
(Provision) benefit for income taxes	-1,192.2	-1,101.4	-502.4	-147.0	24.4	-13.4	-32.8	-42.7
Net income attributable to Bio-Rad	4,245.9	3,806.3	1,758.7	365.6	122.2	28.1	113.1	88.8

Basic earnings per share:
Net income per share basic attributable to Bio-Rad	$142.33	$127.86	$58.93	$12.25	$4.12	$0.96	$3.87	$3.08

Weighted average common shares - basic	29.8	29.8	29.8	29.8	29.7	29.4	29.2	28.9

Diluted earnings per share:
Net income per share diluted attributable to Bio-Rad	$140.56	$126.20	$58.27	$12.10	$4.07	$0.95	$3.85	$3.05
Weighted average common shares - diluted	30.2	30.2	30.2	30.2	30.0	29.6	29.4	29.1